Bosun Asset Management’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$2.04M Hold
2,213
1.09% 15
2025
Q4
$2.38M Sell
2,213
-100
-4% -$95.6K 1.15% 14
2025
Q3
$1.76M Sell
2,313
-138
-6% -$103K 0.91% 15
2025
Q2
$1.91M Sell
2,451
-17
-0.7% -$13.2K 0.57% 32
2025
Q1
$2.04M Sell
2,468
-46
-2% -$38.3K 0.87% 23
2024
Q4
$1.94M Sell
2,514
-115
-4% -$95.2K 0.85% 32
2024
Q3
$2.33M Buy
2,629
+1
+0% +$899 1.11% 22
2024
Q2
$2.38M Sell
2,628
-26
-1% -$20.8K 1.41% 19
2024
Q1
$2.06M Sell
2,654
-146
-5% -$104K 1.18% 14
2023
Q4
$1.63M Buy
2,800
+200
+8% +$117K 1.62% 12
2023
Q3
$1.4M Hold
2,600
1.51% 14
2023
Q2
$1.22M Sell
2,600
-400
-13% -$168K 1.2% 14
2023
Q1
$1.03M Hold
3,000
1.18% 15
2022
Q4
$1.1M Hold
3,000
1.55% 9
2022
Q3
$970K Hold
3,000
1.5% 12
2022
Q2
$973K Hold
3,000
1.34% 15
2022
Q1
$859K Hold
3,000
0.9% 19
2021
Q4
$829K Buy
+3,000
New +$761K 0.75% 20

Other funds holding LLY

Bosun Asset Management's LLY Position: Q1 2026 in Review

Bosun Asset Management held its Eli Lilly (LLY) position steady in Q1 2026 at 2,213 shares worth $2.04M. The position accounts for 1.09% of the portfolio, ranked #15.

Bosun Asset Management first reported a position in LLY in Q4 2021 and has held it in 18 quarters since. The position peaked at $2.38M in Q2 2024. 4,352 funds tracked by Wall St. Rank hold LLY as of Q1 2026.

  • Bosun Asset Management held 2,213 shares of Eli Lilly worth $2.04M as of Q1 2026.
  • Bosun Asset Management left its Eli Lilly share count unchanged in Q1 2026.
  • Eli Lilly made up 1.09% of Bosun Asset Management's portfolio in Q1 2026, its #15 holding.
  • Bosun Asset Management first reported a position in Eli Lilly in Q4 2021 and has held it in 18 quarters since.
  • Bosun Asset Management's Eli Lilly position peaked at $2.38M in Q2 2024.
  • 4,352 funds tracked by Wall St. Rank held Eli Lilly as of Q1 2026.

Based on Bosun Asset Management's 13F filing for Q1 2026, filed 11 May 2026.